Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking your Wegovy injection a day early is generally not recommended. The licensed dosing schedule, reviewed in the Wegovy SmPC and summarised by the NHS semaglutide medicines page, specifies a fixed once-weekly interval. Shifting that interval — even by 24 hours — can alter the steady-state semaglutide level your body maintains, and that matters more than most people realise. If a specific event is forcing you to consider changing injection day, the right conversation is with your prescriber, not a quick decision made at home.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The once-weekly dosing schedule for semaglutide was established through the STEP clinical programme, the largest of which enrolled thousands of adults and tracked outcomes over 68 weeks. The STEP 1 trial published in the New England Journal of Medicine showed roughly 15% average body-weight reduction at the 2.4mg maintenance dose, with participants injecting on the same day each week throughout. The interval is pharmacokinetically significant: semaglutide has a half-life of approximately one week, which is precisely why the once-weekly schedule produces the stable blood levels that drive the medicine's effect. Compress that interval and you raise peak exposure; extend it and the trough drops. Neither extreme is dangerous if it happens once, but they are not designed-for events.
This is a question our prescribers hear most weeks, usually ahead of a holiday, a wedding, or a long-haul flight where the usual injection day falls awkwardly. The answer is nuanced rather than a flat no.
If you want to understand more about how semaglutide works at a pharmacological level, the semaglutide overview on our site covers the mechanism in plain language.
The Wegovy Summary of Product Characteristics (the definitive clinical reference for this medicine) states that if a weekly dose is missed, it can be given as soon as possible provided the next scheduled dose is at least four days away. If fewer than four days remain before the next scheduled dose, skip that missed dose and resume on the usual day. This flexibility implies that an interval as short as roughly four days is tolerated on a one-off basis; it also implies that pulling a dose forward by a single day falls within that window. The NHS semaglutide page reflects this same guidance for missed or delayed doses.
Crucially, the guidance is written for occasional situations, not for routinely moving your injection day by a day every few weeks. If you want to permanently shift your injection day (say, from Monday to Sunday), the approach is to take one dose after a slightly shorter interval as a one-off transition, then continue on the new day consistently. Your prescriber can confirm whether your current dose and tolerance make that switch straightforward for you specifically.
You can find further practical detail on timing questions, including the specific scenarios most people face, at our page on whether you can take Wegovy a day early.
Semaglutide's most common side effects (nausea, loose stools, reduced appetite, and occasional fatigue) tend to peak in the 24–72 hours after each injection and then settle. Many people quietly schedule their injection day around this: Friday evening, for example, so the rough patch falls over the weekend rather than a busy work morning. Shift your injection day early by 24 hours and you shift that window too. Once. That's manageable. But if you're doing it regularly, you lose the predictability you may have built into your week.
If side-effect timing is genuinely difficult (not just occasionally inconvenient) that is worth raising at your next clinical review rather than trying to engineer around it yourself. The titration schedule exists partly to reduce GI burden, and there is sometimes more that can be done. Our Wegovy treatment page explains how the dose escalation works and what to expect at each stage.
For most people the practical question is simpler: you're travelling, or the pharmacist can only see you on Thursday this week rather than Friday. One day earlier, once, with no plan to make a habit of it, is generally within the four-day buffer the SmPC describes, and our guide to taking Wegovy a day early walks through the scenarios where this applies. Still, confirm with your prescriber before doing it.
Taking your injection a day early is not a medical emergency. If you do it once and feel well, you don't need to contact a clinic. What does warrant a call is anything unexpected: severe, persistent stomach pain that extends to your back (seek urgent medical attention for this, as it is a symptom associated with pancreatitis, flagged in MHRA safety guidance), any allergic reaction, or vomiting so persistent you cannot keep fluids down.
For questions that are not urgent (changing your injection day permanently, managing a travel schedule that crosses time zones, or understanding whether your current dose makes early timing riskier) these belong in a prescriber conversation rather than a forum. If you're on a plan where injection timing has already become unpredictable, that is useful information for whoever is reviewing your treatment.
If you're exploring what responsible private Wegovy prescribing actually looks like, our weight-loss treatment overview sets out how clinical review works at every stage, including how repeat prescriptions are handled, and our guidance on eating watermelon on Wegovy is one example of the practical dietary questions our clinical team addresses alongside timing and dosing. Suspected side effects from any medicine can be reported directly to the MHRA via the Yellow Card scheme.
If you're considering starting Wegovy and want your questions answered by a prescriber rather than a search engine, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.